Because of the established roles that both CA IX and CA XII play in the process of tumorigenesis, cancer cell signaling, tumor progression, acidification, and metastasis, many classes of CA IX/CA XII-targeted inhibitors and biologics have been studied in the preclinical setting. Here, CA9 is linked to cancer.